Thanks buc - let's hope we're both right about this one. Good...

Thanks buc - let's hope we're both right about this one.

Good point about no dilution. I agree that's a good sign - the company has managed to stand on its own two feet despite the tough times it's been through.

Another positive is that the three current directors have bought a total of around $60 000 worth of SRH shares on market in the last 12 months. That's not a huge amount, but it's not a trifling amount either. I mean you don't put that much money in if you don't believe the potential rewards outweigh the risks.

Speaking of the directors, it seems like a well balanced team to me. I don't know any of them personally - I'm only going by the profiles presented in the last annual report:

Darren Hotchkin - the innovator/entrepreneur.

David Cleland - manufacturing and distribution background - should be good for building relations with SRH's customer base, its suppliers and any joint-venture partners.

David Ashmore - no directly relevant industry experience, but I'd imagine he's strong in the fields of risk management / strategic planning / providing wise counsel.

If these three can stay together and harness each other's strengths, I would be quietly confident that the SRH turnaround can continue.

A correction to my previous post. On the chart, the downtrendline I mentioned extends from the peak in 2007 (not 2008). It's a well defined trendline - started in 2007, and was tested in 2008, 2010, 2013 and twice in 2014. Nothing is definite in charting, but to me the fact that the trendline has been broken is a pretty strong signal that the trend has changed.